- Home
- FENC vs GHI Comparison
FENC vs GHI Comparison
Compare FENC & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- GHI
- Stock Information
- Founded
- FENC 1996
- GHI 1998
- Country
- FENC United States
- GHI United States
- Employees
- FENC N/A
- GHI N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- GHI Finance: Consumer Services
- Sector
- FENC Health Care
- GHI Finance
- Exchange
- FENC Nasdaq
- GHI Nasdaq
- Market Cap
- FENC 225.4M
- GHI 254.1M
- IPO Year
- FENC 2001
- GHI N/A
- Fundamental
- Price
- FENC $8.67
- GHI $10.80
- Analyst Decision
- FENC Strong Buy
- GHI Strong Buy
- Analyst Count
- FENC 2
- GHI 4
- Target Price
- FENC $13.50
- GHI $14.88
- AVG Volume (30 Days)
- FENC 54.7K
- GHI 50.9K
- Earning Date
- FENC 11-06-2025
- GHI 11-05-2025
- Dividend Yield
- FENC N/A
- GHI 13.72%
- EPS Growth
- FENC N/A
- GHI N/A
- EPS
- FENC N/A
- GHI N/A
- Revenue
- FENC $33,302,000.00
- GHI $27,326,828.00
- Revenue This Year
- FENC $0.96
- GHI $228.92
- Revenue Next Year
- FENC $51.71
- GHI $4.27
- P/E Ratio
- FENC N/A
- GHI N/A
- Revenue Growth
- FENC N/A
- GHI N/A
- 52 Week Low
- FENC $3.96
- GHI $10.12
- 52 Week High
- FENC $9.42
- GHI $14.51
- Technical
- Relative Strength Index (RSI)
- FENC 48.27
- GHI 49.30
- Support Level
- FENC $8.96
- GHI $10.65
- Resistance Level
- FENC $9.13
- GHI $10.90
- Average True Range (ATR)
- FENC 0.28
- GHI 0.21
- MACD
- FENC -0.02
- GHI 0.01
- Stochastic Oscillator
- FENC 17.88
- GHI 55.77
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.